Double-Duty Nanoparticles Overcome Drug Resistance in Tumors

Jun 14, 2007

Cancer cells, like bacteria, can develop resistance to drug therapy. In fact, research suggests strongly that multidrug resistant cancer cells that remain alive after chemotherapy are responsible for the reappearance of tumors and the poor prognosis for patients whose cancer recurs. Indeed, multidrug resistance occurs in over 50% of patients whose ovarian cancer relapses, accounting in large part for the high mortality associated with ovarian cancer.

In an attempt to circumvent the mechanisms that cancer cells use to avoid cell death following chemotherapy, researchers at Northeastern University, led by Mansoor Amiji, Ph.D., have created a polymeric nanoparticle that delivers a one-two punch to multidrug resistant ovarian cancer cells.

The first blow comes from the drug ceramide, which overwhelms an enzyme that drug-resistant tumor cells use to avoid apoptosis, the programmed cell death that chemotherapy triggers.

The nanoparticle delivers its second blow in the form of paclitaxel, a potent anticancer agent used as a first-line therapy for ovarian cancer. Amiji, the principal investigator of one of the National Cancer Institute's Cancer Nanotechnology Platform Partnerships, and his colleagues published their results in the journal Cancer Research.

Using drug-resistant ovarian cancer cells growing in culture, the investigators showed that treatment with the multifunctional nanoparticle produced 100% mortality among the cultured cells. Moreover, ceramide co-therapy sensitized the drug-resistant cells to such a degree that they became as sensitive to the cell-killing effects of paclitaxel as are non-drug-resistant ovarian tumor cells. The researchers note that followup experiments showed that nanoparticle-delivered ceramide, in fact, did restore the drug-resistant cells' ability to undergo apoptosis.

This work, which was supported by the National Cancer Institute's Alliance for Nanotechnology in Cancer, is detailed in the paper "Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer." Investigators from the Massachusetts General Hospital also participated in this study. An abstract of this paper is available through PubMed.

Source: National Cancer Institute

Explore further: Tough foam from tiny sheets

add to favorites email to friend print save as pdf

Related Stories

Discovery of a primordial cancer in a primitive animal

Jun 24, 2014

Every year around 450,000 people in Germany are diagnosed with cancer. Each one of them dreams of a victory in the battle against it. But can cancer ever be completely defeated? Researchers at Kiel University ...

'Nanodaisies' deliver drug cocktail to cancer cells

May 28, 2014

(Phys.org) —Biomedical engineering researchers have developed daisy-shaped, nanoscale structures that are made predominantly of anti-cancer drugs and are capable of introducing a "cocktail" of multiple ...

Fine tuning an old-school chemotherapy drug

May 05, 2014

First approved by the FDA in the 1970s, the chemotherapy drug cisplatin and its relative carboplatin remain mainstays of treatment for lung, head and neck, testicular and ovarian cancer. However, cisplatin's ...

Recommended for you

Tough foam from tiny sheets

9 hours ago

Tough, ultralight foam of atom-thick sheets can be made to any size and shape through a chemical process invented at Rice University.

Graphene surfaces on photonic racetracks

Jul 28, 2014

In an article published in Optics Express, scientists from The University of Manchester describe how graphene can be wrapped around a silicon wire, or waveguide, and modify the transmission of light through it.

Simulating the invisible

Jul 28, 2014

Panagiotis Grammatikopoulos in the OIST Nanoparticles by Design Unit simulates the interactions of particles that are too small to see, and too complicated to visualize. In order to study the particles' behavior, he uses ...

Building 'invisible' materials with light

Jul 28, 2014

A new method of building materials using light, developed by researchers at the University of Cambridge, could one day enable technologies that are often considered the realm of science fiction, such as invisibility ...

User comments : 0